PHARMACOKINETICS AND PHARMACODYNAMICS OF GS-1423, A FIRST-IN-CLASS BIFUNCTIONAL ANTIBODY TARGETING CD73 AND TGFB, IN SUBJECTS WITH ADVANCED TUMORS.

C. Hsueh, M. Zavodovskaya,T. Tarnowski, A. Tolcher,M. Gordon,J. Strauss, K. Ma-Honey, J. Juergensmeier, T. Chen,A. Othman

CLINICAL PHARMACOLOGY & THERAPEUTICS（2022）

Cited 0|Views15

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined